Cannabis concentrate is a highly concentrated and potent THC- (Tetrahydrocannabinol) concentrated mass that contains extraordinarily high THC levels ranging from 40 to 80 percent THC amounts.   

Being a highly concentrated form of marijuana, the effects upon the user may be more psychologically and physically intense than plant marijuana use. 

Cannabis concentrates outsold flower for the first time in history,  comprising 37 percent of all cannabis sales in California. According to figures from BDS Analytics, concentrates outperformed flower by 4 percent in 2018. This is a huge jump from 2014, when flower dominated 67 percent of the then nascent Colorado market.

Medicinal Organic Cannabis Australia (MOCA)'s audience, is a rapidly growing global market of people who seek wellness and relief from illness and an enhanced quality of life. Around the world, patients are seeking innovative emerging medical solutions to restore health and alleviate sickness. MOCA has developed a business case and is preparing to supply the Australian market with high quality, organic, sustainable grown cannabis medication. 

According to a report by Zion Market Research, the global cannabis concentrate market sat at USD $3.73 billion in 2018, and is expected to generate around USD $13.78 billion by 2026.

Cannabis use is on the rise, vaping is on the rise, and yet flower sales are going down. It doesn’t take a rocket scientist to see where this puck is going.